Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6

Aiming Yu, Haijun Dong, Dieter Lang, Robert L. Haining

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The O-demethylation of dextromethorphan to dextrorphan in humans is catalyzed primarily by cytochrome P450 2D6 (CYP2D6). However, contrary to conventional wisdom, preparations of recombinant cytochrome P450 (P450) expressed from CYP2D6*1 cDNA also appear to produce significant amounts of 3-methoxymorphinan, the N-demethylated metabolite of dextromethorphan, when assayed in vitro, We hypothesized that both pathways were intrinsic to 2D6 and here further examine the kinetics of formation using a highly purified preparation of CYP2D6 in a reconstituted lipid system. Purified CYP2D6 protein with a measured molecular weight of 55772.0 (55769.6 Da predicted) was reconstituted into an active, lipid-vesicle environment with purified rat cytochrome P450 reductase before the addition of substrate and NADPH. Reaction kinetics were followed, and apparent Michaelis-Menten constants were determined for the appearance of each metabolite by high-pressure liquid chromatography, using both UV and fluorescence detection. In a 2-min assay, purified 2D6 catalyzed the formation of dextrorphan with an apparent Km value of 1.9 ± 0.2 μM and a Vmax value of 8.5 ± 0.2 nmol/nmol of P450/min and measured simultaneously the formation of 3-methoxymorphinan with an apparent Km value of 5000 ± 700 μM and Vmax value of 176 ± 12 nmol (nmol of P450)-1 min-1. These results indicate that at least two distinct binding orientations exist for dextromethorphan within the active site of CYP2D6.

Original languageEnglish (US)
Pages (from-to)1362-1365
Number of pages4
JournalDrug Metabolism and Disposition
Volume29
Issue number11
StatePublished - 2001
Externally publishedYes

Fingerprint

Dextromethorphan
Cytochrome P-450 CYP2D6
Dextrorphan
Metabolites
High pressure liquid chromatography
Lipids
NADPH-Ferrihemoprotein Reductase
NADP
Reaction kinetics
Cytochrome P-450 Enzyme System
Rats
Assays
Catalytic Domain
Complementary DNA
Molecular Weight
Fluorescence
Molecular weight
High Pressure Liquid Chromatography
Kinetics
Substrates

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6. / Yu, Aiming; Dong, Haijun; Lang, Dieter; Haining, Robert L.

In: Drug Metabolism and Disposition, Vol. 29, No. 11, 2001, p. 1362-1365.

Research output: Contribution to journalArticle

@article{cbe4f6034bf1431fab9137a95897d614,
title = "Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6",
abstract = "The O-demethylation of dextromethorphan to dextrorphan in humans is catalyzed primarily by cytochrome P450 2D6 (CYP2D6). However, contrary to conventional wisdom, preparations of recombinant cytochrome P450 (P450) expressed from CYP2D6*1 cDNA also appear to produce significant amounts of 3-methoxymorphinan, the N-demethylated metabolite of dextromethorphan, when assayed in vitro, We hypothesized that both pathways were intrinsic to 2D6 and here further examine the kinetics of formation using a highly purified preparation of CYP2D6 in a reconstituted lipid system. Purified CYP2D6 protein with a measured molecular weight of 55772.0 (55769.6 Da predicted) was reconstituted into an active, lipid-vesicle environment with purified rat cytochrome P450 reductase before the addition of substrate and NADPH. Reaction kinetics were followed, and apparent Michaelis-Menten constants were determined for the appearance of each metabolite by high-pressure liquid chromatography, using both UV and fluorescence detection. In a 2-min assay, purified 2D6 catalyzed the formation of dextrorphan with an apparent Km value of 1.9 ± 0.2 μM and a Vmax value of 8.5 ± 0.2 nmol/nmol of P450/min and measured simultaneously the formation of 3-methoxymorphinan with an apparent Km value of 5000 ± 700 μM and Vmax value of 176 ± 12 nmol (nmol of P450)-1 min-1. These results indicate that at least two distinct binding orientations exist for dextromethorphan within the active site of CYP2D6.",
author = "Aiming Yu and Haijun Dong and Dieter Lang and Haining, {Robert L.}",
year = "2001",
language = "English (US)",
volume = "29",
pages = "1362--1365",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "11",

}

TY - JOUR

T1 - Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6

AU - Yu, Aiming

AU - Dong, Haijun

AU - Lang, Dieter

AU - Haining, Robert L.

PY - 2001

Y1 - 2001

N2 - The O-demethylation of dextromethorphan to dextrorphan in humans is catalyzed primarily by cytochrome P450 2D6 (CYP2D6). However, contrary to conventional wisdom, preparations of recombinant cytochrome P450 (P450) expressed from CYP2D6*1 cDNA also appear to produce significant amounts of 3-methoxymorphinan, the N-demethylated metabolite of dextromethorphan, when assayed in vitro, We hypothesized that both pathways were intrinsic to 2D6 and here further examine the kinetics of formation using a highly purified preparation of CYP2D6 in a reconstituted lipid system. Purified CYP2D6 protein with a measured molecular weight of 55772.0 (55769.6 Da predicted) was reconstituted into an active, lipid-vesicle environment with purified rat cytochrome P450 reductase before the addition of substrate and NADPH. Reaction kinetics were followed, and apparent Michaelis-Menten constants were determined for the appearance of each metabolite by high-pressure liquid chromatography, using both UV and fluorescence detection. In a 2-min assay, purified 2D6 catalyzed the formation of dextrorphan with an apparent Km value of 1.9 ± 0.2 μM and a Vmax value of 8.5 ± 0.2 nmol/nmol of P450/min and measured simultaneously the formation of 3-methoxymorphinan with an apparent Km value of 5000 ± 700 μM and Vmax value of 176 ± 12 nmol (nmol of P450)-1 min-1. These results indicate that at least two distinct binding orientations exist for dextromethorphan within the active site of CYP2D6.

AB - The O-demethylation of dextromethorphan to dextrorphan in humans is catalyzed primarily by cytochrome P450 2D6 (CYP2D6). However, contrary to conventional wisdom, preparations of recombinant cytochrome P450 (P450) expressed from CYP2D6*1 cDNA also appear to produce significant amounts of 3-methoxymorphinan, the N-demethylated metabolite of dextromethorphan, when assayed in vitro, We hypothesized that both pathways were intrinsic to 2D6 and here further examine the kinetics of formation using a highly purified preparation of CYP2D6 in a reconstituted lipid system. Purified CYP2D6 protein with a measured molecular weight of 55772.0 (55769.6 Da predicted) was reconstituted into an active, lipid-vesicle environment with purified rat cytochrome P450 reductase before the addition of substrate and NADPH. Reaction kinetics were followed, and apparent Michaelis-Menten constants were determined for the appearance of each metabolite by high-pressure liquid chromatography, using both UV and fluorescence detection. In a 2-min assay, purified 2D6 catalyzed the formation of dextrorphan with an apparent Km value of 1.9 ± 0.2 μM and a Vmax value of 8.5 ± 0.2 nmol/nmol of P450/min and measured simultaneously the formation of 3-methoxymorphinan with an apparent Km value of 5000 ± 700 μM and Vmax value of 176 ± 12 nmol (nmol of P450)-1 min-1. These results indicate that at least two distinct binding orientations exist for dextromethorphan within the active site of CYP2D6.

UR - http://www.scopus.com/inward/record.url?scp=0034771887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034771887&partnerID=8YFLogxK

M3 - Article

C2 - 11602510

AN - SCOPUS:0034771887

VL - 29

SP - 1362

EP - 1365

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 11

ER -